Literature DB >> 47617

Antibody to a molecularly-defined antigen confined to a tumour cell surface.

G T Stevenson, F K Stevenson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 47617     DOI: 10.1038/254714a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  33 in total

1.  Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma.

Authors:  Stephen J Schuster; Sattva S Neelapu; Barry L Gause; John E Janik; Franco M Muggia; Jon P Gockerman; Jane N Winter; Christopher R Flowers; Daniel A Nikcevich; Eduardo M Sotomayor; Dean S McGaughey; Elaine S Jaffe; Elise A Chong; Craig W Reynolds; Donald A Berry; Carlos F Santos; Mihaela A Popa; Amy M McCord; Larry W Kwak
Journal:  J Clin Oncol       Date:  2011-05-31       Impact factor: 44.544

Review 2.  Idiotype vaccines for lymphoma: proof-of-principles and clinical trial failures.

Authors:  Maurizio Bendandi
Journal:  Nat Rev Cancer       Date:  2009-09       Impact factor: 60.716

Review 3.  Developing idiotype vaccines for lymphoma: from preclinical studies to phase III clinical trials.

Authors:  Hyun Jun Park; Sattva S Neelapu
Journal:  Br J Haematol       Date:  2008-04-13       Impact factor: 6.998

Review 4.  Towards an off-the-shelf vaccine therapy targeting shared B-cell tumor idiotypes.

Authors:  Flavio E Baio; Larry W Kwak; Jinsheng Weng
Journal:  Am J Blood Res       Date:  2014-12-15

5.  Some effects on leukaemic B lymphocytes of antibodies to defined regions of their surface immunoglobulin.

Authors:  F K Stevenson; E V Elliott; G T Stevenson
Journal:  Immunology       Date:  1977-04       Impact factor: 7.397

6.  Preferential expression of IgG1 antibodies specific for L2C leukaemia IgM idiotypic determinants in tumour-protected strain 2 guinea-pigs.

Authors:  M J Ricardo; D T Grimm
Journal:  Immunology       Date:  1983-04       Impact factor: 7.397

Review 7.  Treatment of lymphoid tumors with anti-idiotype antibodies.

Authors:  G T Stevenson; F K Stevenson
Journal:  Springer Semin Immunopathol       Date:  1983

8.  Dynamic studies of lymphocytes labelled with indium-111 during and after treatment with monoclonal anti-idiotype antibody in advanced B cell lymphoma.

Authors:  E M Rankin; A Hekman; M R Hardeman; C A Hoefnagel
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-27

9.  Insight into the potential for DNA idiotypic fusion vaccines designed for patients by analysing xenogeneic anti-idiotypic antibody responses.

Authors:  Francesco Forconi; Catherine A King; Surinder S Sahota; Christopher K Kennaway; Nigel H Russell; Freda K Stevenson
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

10.  Immunotherapy of B lymphoma by anti-idiotype antibodies: characterization of variant tumour cells appearing a long time after the initial tumour inoculation.

Authors:  M Taya; J Haimovich
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.